Skip to main content
Erschienen in: Der Radiologe 3/2018

01.03.2018 | Demenz | CME

Neurodegenerative Erkrankungen

verfasst von: Prof. Dr. med. Wolfgang Reith

Erschienen in: Die Radiologie | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Neurodegenerative Erkrankungen sind sporadische und seltene, erblich auftretende Störungen des zentralen Nervensystems, bei denen es zu einem langsam progredienten Funktionsverlust spezifischer Neuronenpopulationen und ihrer Verbindungen kommt. Schwere Behinderungen und Pflegbedürftigkeit können die Folge sein. Neurodegenerative Störungen sind Erkrankungen des älteren Menschen. Entsprechend lässt der demografische Wandel die Zahl der betroffenen Patienten deutlich steigen. Auch den Radiologen werden die Erkrankungen vermehrt beschäftigen. Aus diesem Grund sollen im vorliegenden Beitrag wichtige neurodegenerative Erkrankungen vorgestellt werden: Neben der Alzheimer- und Parkinson-Erkrankung gehören hierzu die frontotemporale Lobärdegeneration, die Lewy-Körperchen-Demenz, vaskuläre Demenzen, die Creutzfeldt-Jakob-Krankheit und die Chorea Huntington. Beschrieben werden das klinische Bild und die Diagnostik, wobei ein Schwerpunkt auf typischen bildmorphologischen Befunden liegt.
Literatur
1.
Zurück zum Zitat Ziegler U, Doblhammer G (2009) Prevalence and incidence of dementia in Germany – a study based on data from the public sick funds in 2002. Gesundheitswesen 71:281–290CrossRefPubMed Ziegler U, Doblhammer G (2009) Prevalence and incidence of dementia in Germany – a study based on data from the public sick funds in 2002. Gesundheitswesen 71:281–290CrossRefPubMed
2.
Zurück zum Zitat Qiu C, De Ronchi D, Fratiglioni L (2007) The epidemiology of the dementias: an update. Curr Opin Psychiatry 20:380–385CrossRefPubMed Qiu C, De Ronchi D, Fratiglioni L (2007) The epidemiology of the dementias: an update. Curr Opin Psychiatry 20:380–385CrossRefPubMed
3.
Zurück zum Zitat Hobson P, Meara J (2004) Risk and incidence of dementia in a cohort of older subjects with Parkinson’s disease in the United Kingdom. Mov Disord 19:1043–1049CrossRefPubMed Hobson P, Meara J (2004) Risk and incidence of dementia in a cohort of older subjects with Parkinson’s disease in the United Kingdom. Mov Disord 19:1043–1049CrossRefPubMed
4.
Zurück zum Zitat Working Group on Molecular and Biochemical Markers of Alzheimer’s Disease (1998) Consensus report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”. The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association and the National Institute on Aging Working Group. Neurobiol Aging 19:109–116CrossRef Working Group on Molecular and Biochemical Markers of Alzheimer’s Disease (1998) Consensus report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”. The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association and the National Institute on Aging Working Group. Neurobiol Aging 19:109–116CrossRef
5.
Zurück zum Zitat Frankfort SV, Tulner LR, van Campen JP et al (2008) Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature. Curr Clin Pharmacol 3:123–131CrossRefPubMed Frankfort SV, Tulner LR, van Campen JP et al (2008) Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature. Curr Clin Pharmacol 3:123–131CrossRefPubMed
7.
Zurück zum Zitat O’Brien JT (2007) Role of imaging techniques in the diagnosis of dementia. Br J Radiol 80:71–77CrossRef O’Brien JT (2007) Role of imaging techniques in the diagnosis of dementia. Br J Radiol 80:71–77CrossRef
8.
Zurück zum Zitat Herholz K, Carter SF, Jones M (2007) Positron emission tomography imaging in dementia. Br J Radiol 80:160–167CrossRef Herholz K, Carter SF, Jones M (2007) Positron emission tomography imaging in dementia. Br J Radiol 80:160–167CrossRef
9.
Zurück zum Zitat Dubois B, Feldman HH, Jacova C et al (2010) Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol 9:1118–1127CrossRefPubMed Dubois B, Feldman HH, Jacova C et al (2010) Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol 9:1118–1127CrossRefPubMed
10.
Zurück zum Zitat Dubois B, Feldman HH, Jacova C et al (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734–746CrossRefPubMed Dubois B, Feldman HH, Jacova C et al (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734–746CrossRefPubMed
12.
Zurück zum Zitat Frisoni GB et al (2011) Revised NIA-AA criteria for the diagnosis of Alzheimer’s disease: a step forward but not yet ready for widespread clinical use. Int Psychogeriatr 23:8,1191–1196CrossRefPubMed Frisoni GB et al (2011) Revised NIA-AA criteria for the diagnosis of Alzheimer’s disease: a step forward but not yet ready for widespread clinical use. Int Psychogeriatr 23:8,1191–1196CrossRefPubMed
13.
Zurück zum Zitat Andreasen N, Blennow K (2005) CSF biomarkers for mild cognitive impairment and early Alzheimer’s disease. Clin Neurol Neurosurg 107:165–173CrossRefPubMed Andreasen N, Blennow K (2005) CSF biomarkers for mild cognitive impairment and early Alzheimer’s disease. Clin Neurol Neurosurg 107:165–173CrossRefPubMed
14.
Zurück zum Zitat Zakzanis KK, Graham SJ, Campbell Z (2003) A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer’s type: a neuroimaging profile. Neuropsychol Rev 13:1–18CrossRefPubMed Zakzanis KK, Graham SJ, Campbell Z (2003) A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer’s type: a neuroimaging profile. Neuropsychol Rev 13:1–18CrossRefPubMed
15.
Zurück zum Zitat Foster NL, Heidebrink JL, Clark CM et al (2007) FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer’s disease. Brain 130:2616–2635CrossRefPubMed Foster NL, Heidebrink JL, Clark CM et al (2007) FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer’s disease. Brain 130:2616–2635CrossRefPubMed
16.
Zurück zum Zitat Braak BHE (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239–259CrossRefPubMed Braak BHE (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239–259CrossRefPubMed
18.
Zurück zum Zitat Jack CR Jr, Wiste HJ, Weigand SD et al (2014) Age-specific population frequencies of cerebral β‑amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study. Lancet Neurol 13:997–1005CrossRefPubMedPubMedCentral Jack CR Jr, Wiste HJ, Weigand SD et al (2014) Age-specific population frequencies of cerebral β‑amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study. Lancet Neurol 13:997–1005CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Clark CM, Pontecorvo MJ, Beach TG et al (2012) Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol 11:669–678CrossRefPubMed Clark CM, Pontecorvo MJ, Beach TG et al (2012) Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol 11:669–678CrossRefPubMed
20.
Zurück zum Zitat Sperling RA et al (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging – Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280–292CrossRefPubMedPubMedCentral Sperling RA et al (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging – Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280–292CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Targosz-Gajniak M, Siuda J, Ochudlo S et al (2009) Cerebral white matter lesions in patients with dementia – from MCI to severe Alzheimer’s disease. J Neurol Sci 283:79–82CrossRefPubMed Targosz-Gajniak M, Siuda J, Ochudlo S et al (2009) Cerebral white matter lesions in patients with dementia – from MCI to severe Alzheimer’s disease. J Neurol Sci 283:79–82CrossRefPubMed
22.
23.
Zurück zum Zitat Nasreddine ZS, Phillips NA, Bédirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRefPubMed Nasreddine ZS, Phillips NA, Bédirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRefPubMed
24.
Zurück zum Zitat Matthews FE, Stephan BC, McKeith IG et al (2008) Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J Am Geriatr Soc 56:1424–1433CrossRefPubMed Matthews FE, Stephan BC, McKeith IG et al (2008) Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J Am Geriatr Soc 56:1424–1433CrossRefPubMed
25.
Zurück zum Zitat Steinbart EJ, Smith CO, Poorkaj P, Bird TD (2001) Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia. Arch Neurol 58:1828–1831CrossRefPubMed Steinbart EJ, Smith CO, Poorkaj P, Bird TD (2001) Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia. Arch Neurol 58:1828–1831CrossRefPubMed
26.
Zurück zum Zitat McKeith I, O’Brien J, Walker Z et al (2007) Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 6:305–313CrossRefPubMed McKeith I, O’Brien J, Walker Z et al (2007) Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 6:305–313CrossRefPubMed
27.
Zurück zum Zitat Lowther E, O’Brien J, Firbank M, Blamire A (2014) Lewy body compared with Alzheimer dementia is associated with decreased functional connectivity in resting state networks. Psychiatry Res 223(3):192–201CrossRefPubMed Lowther E, O’Brien J, Firbank M, Blamire A (2014) Lewy body compared with Alzheimer dementia is associated with decreased functional connectivity in resting state networks. Psychiatry Res 223(3):192–201CrossRefPubMed
28.
Zurück zum Zitat Walker Z, Costa D, Walker R, Shaw K, Gacinovic S, Stevens T et al (2002) Differentiation of dementia with Lewy bodies from Alzheimer’s disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatr 73:134–140CrossRef Walker Z, Costa D, Walker R, Shaw K, Gacinovic S, Stevens T et al (2002) Differentiation of dementia with Lewy bodies from Alzheimer’s disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatr 73:134–140CrossRef
29.
Zurück zum Zitat Ballard C, O’Brien J, Gray A, Cormack F, Ayre G, Rowan E et al (2001) Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease. Arch Neurol 58:977–982CrossRefPubMed Ballard C, O’Brien J, Gray A, Cormack F, Ayre G, Rowan E et al (2001) Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease. Arch Neurol 58:977–982CrossRefPubMed
30.
Zurück zum Zitat Von Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C, Poewe W, Oertel W, Siebert U, Berger K, Dodel R (2005) Prevalence and incidence of Parkinson’s disease in Europe. Eur Neuropsychopharmacol 15(4):473–490CrossRef Von Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C, Poewe W, Oertel W, Siebert U, Berger K, Dodel R (2005) Prevalence and incidence of Parkinson’s disease in Europe. Eur Neuropsychopharmacol 15(4):473–490CrossRef
31.
Zurück zum Zitat Oertel W, Deuschl G, Poewe W (2012) Parkinson-Syndrome und andere Bewegungsstörungen. Thieme, StuttgartCrossRef Oertel W, Deuschl G, Poewe W (2012) Parkinson-Syndrome und andere Bewegungsstörungen. Thieme, StuttgartCrossRef
32.
Zurück zum Zitat Oba H, Yagishita A, Terada H, Barkovich AJ, Kutomi K, Yamauchi T, Furui S, Shimizu T, Uchigata M, Matsumura K, Sonoo M, Sakai M, Takada K, Harasawa A, Takeshita K, Kohtake H, Tanaka H, Suzuki S (2005) New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 64(12):2050–2055CrossRefPubMed Oba H, Yagishita A, Terada H, Barkovich AJ, Kutomi K, Yamauchi T, Furui S, Shimizu T, Uchigata M, Matsumura K, Sonoo M, Sakai M, Takada K, Harasawa A, Takeshita K, Kohtake H, Tanaka H, Suzuki S (2005) New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 64(12):2050–2055CrossRefPubMed
33.
Zurück zum Zitat Reith W (2011) Gehirn. In: Vogl J, Reith W, Rummeny EJ (Hrsg) Diagnostische und Interventionelle Radiologie. Springer, Berlin Heidelberg Reith W (2011) Gehirn. In: Vogl J, Reith W, Rummeny EJ (Hrsg) Diagnostische und Interventionelle Radiologie. Springer, Berlin Heidelberg
34.
Zurück zum Zitat AWMF (2016) S3 Leitlinie Parkinson (Registriernummer:030-010) AWMF (2016) S3 Leitlinie Parkinson (Registriernummer:030-010)
35.
Zurück zum Zitat Jellinger KA, Attems J (2007) Neuropathological evaluation of mixed dementia. J Neurol Sci 257:80–87CrossRefPubMed Jellinger KA, Attems J (2007) Neuropathological evaluation of mixed dementia. J Neurol Sci 257:80–87CrossRefPubMed
36.
Zurück zum Zitat Block F, Dafotakis M (2017) Zerebrale Amyloiangiopathie in der Schlaganfallmedizin. Dtsch Arztebl Int 114:37–42PubMedPubMedCentral Block F, Dafotakis M (2017) Zerebrale Amyloiangiopathie in der Schlaganfallmedizin. Dtsch Arztebl Int 114:37–42PubMedPubMedCentral
37.
Zurück zum Zitat Linn J, Halpin A, Demaerel P et al (2010) Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 74:1346–1350CrossRefPubMedPubMedCentral Linn J, Halpin A, Demaerel P et al (2010) Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 74:1346–1350CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Greenberg SM, Vernooij MW, Cordoniier C, Viswatnathan A, Al-Shai Salman R, Warach S et al (2009) Cererbal microbleeds a guide to detection and interpretation. Lancet Neurol 8:165–174CrossRefPubMedPubMedCentral Greenberg SM, Vernooij MW, Cordoniier C, Viswatnathan A, Al-Shai Salman R, Warach S et al (2009) Cererbal microbleeds a guide to detection and interpretation. Lancet Neurol 8:165–174CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Dichgans M, Mayer M, Brüning R, Ebke M, Gasser T (1997) Erbliche Mikroangiopathie: CADASIL. Dtsch Arztebl 94:227–230 Dichgans M, Mayer M, Brüning R, Ebke M, Gasser T (1997) Erbliche Mikroangiopathie: CADASIL. Dtsch Arztebl 94:227–230
40.
Zurück zum Zitat Gallia GL, Rigamonti D, Williams MA (2006) The diagnosis and treatment of idiopathic normal pressure hydrocephalus. Nat Clin Pract Neurol 2:375–381CrossRefPubMed Gallia GL, Rigamonti D, Williams MA (2006) The diagnosis and treatment of idiopathic normal pressure hydrocephalus. Nat Clin Pract Neurol 2:375–381CrossRefPubMed
41.
Zurück zum Zitat Conn HO (2011) Normal pressure hydrocephalus (NPH): more about NPH by a physician who is the patient treatment of idiopathic normal pressure hydrocephalus. Clin Med (Lond) 11(2):162–165CrossRef Conn HO (2011) Normal pressure hydrocephalus (NPH): more about NPH by a physician who is the patient treatment of idiopathic normal pressure hydrocephalus. Clin Med (Lond) 11(2):162–165CrossRef
42.
Zurück zum Zitat Sakakibara R, Uchiyama T, Kanda T, Uchida Y, Kishi M, Hattori T (2008) Urinary dysfunction in idiopathic normal pressure hydrocephalus. Brain Nerve 3:233–239 Sakakibara R, Uchiyama T, Kanda T, Uchida Y, Kishi M, Hattori T (2008) Urinary dysfunction in idiopathic normal pressure hydrocephalus. Brain Nerve 3:233–239
43.
Zurück zum Zitat Longatti PL, Fiorindi A, Martinuzzi A (2004) Failure of endoscopic third ventriculostomy in the treatment of idiopathic normal pressure hydrocephalus. Minim Invasive Neurosurg 47(6):342–345CrossRefPubMed Longatti PL, Fiorindi A, Martinuzzi A (2004) Failure of endoscopic third ventriculostomy in the treatment of idiopathic normal pressure hydrocephalus. Minim Invasive Neurosurg 47(6):342–345CrossRefPubMed
44.
Zurück zum Zitat Leitlinien für Diagnostik und Therapie in der Neurologie, AWMF-Registernummer: 030/042, 2002 Leitlinien für Diagnostik und Therapie in der Neurologie, AWMF-Registernummer: 030/042, 2002
45.
Zurück zum Zitat Tschampa HJ, Zerr I, Kallenberg K et al (2007) Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 28:1114–1118CrossRefPubMed Tschampa HJ, Zerr I, Kallenberg K et al (2007) Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 28:1114–1118CrossRefPubMed
46.
Zurück zum Zitat Cardoso F, Seppi K, Mair KJ, Wenning GK, Poewe W (2006) Seminar on choreas. Lancet Neurol 5(7):589–602CrossRefPubMed Cardoso F, Seppi K, Mair KJ, Wenning GK, Poewe W (2006) Seminar on choreas. Lancet Neurol 5(7):589–602CrossRefPubMed
47.
Zurück zum Zitat Chang KH, Tsou JC, Chen ST, Ro LS, Lyu RK, Chang HS et al (2010) Temporal features of magnetic resonance imaging and spectroscopy in non-ketotic hyperglycemic chorea-ballism patients. Eur J Neurol 17(4):589–593CrossRefPubMed Chang KH, Tsou JC, Chen ST, Ro LS, Lyu RK, Chang HS et al (2010) Temporal features of magnetic resonance imaging and spectroscopy in non-ketotic hyperglycemic chorea-ballism patients. Eur J Neurol 17(4):589–593CrossRefPubMed
48.
Zurück zum Zitat Killoran A, Biglan KM (2014) Current therapeutic options for Huntington’s disease: good clinical practice versus evidence-based approaches? Mov Disord 29(11):1404–1413CrossRefPubMed Killoran A, Biglan KM (2014) Current therapeutic options for Huntington’s disease: good clinical practice versus evidence-based approaches? Mov Disord 29(11):1404–1413CrossRefPubMed
49.
Zurück zum Zitat Bougard D, Brandel J‑P, Belondrade V, Beringue V, Segarra C, Fleury H, Laplache J‑L, Mayran C, Nicot S, Green A, Welaratne A, Narbey D, Fournier-wirth C, Knight R, Will R, Tiberghien P, Haik S, Coste J (2016) Detections of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeld-Jakob disease. Sci Transl Med 8(370):370ra182. https://doi.org/10.1126/scitranslmed.aag1257 CrossRefPubMed Bougard D, Brandel J‑P, Belondrade V, Beringue V, Segarra C, Fleury H, Laplache J‑L, Mayran C, Nicot S, Green A, Welaratne A, Narbey D, Fournier-wirth C, Knight R, Will R, Tiberghien P, Haik S, Coste J (2016) Detections of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeld-Jakob disease. Sci Transl Med 8(370):370ra182. https://​doi.​org/​10.​1126/​scitranslmed.​aag1257 CrossRefPubMed
Metadaten
Titel
Neurodegenerative Erkrankungen
verfasst von
Prof. Dr. med. Wolfgang Reith
Publikationsdatum
01.03.2018
Verlag
Springer Medizin
Erschienen in
Die Radiologie / Ausgabe 3/2018
Print ISSN: 2731-7048
Elektronische ISSN: 2731-7056
DOI
https://doi.org/10.1007/s00117-018-0363-y

Weitere Artikel der Ausgabe 3/2018

Der Radiologe 3/2018 Zur Ausgabe

Einführung zum Thema

Evolution auf leisen Sohlen

Informationstechnologie und Management

Medizin im digitalen Zeitalter

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.